Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|4|498-509

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.4, 2009-04, pp. : 498-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein tyrosine kinase inhibitors as anticancer agents

By Supuran Claudiu T   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R   Goekjian Peter G  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite

The Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1961-1973

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Protein Kinase C (PKC) in Physiology and Cancer of the Gastric Cell System

By  

Current Medicinal Chemistry, Vol. 15, Iss. 12, 2008-05 ,pp. : 1175-1191

Bentham Science Publishers

Access to resources Recommend Favorite

Developments of DNA-dependent Protein Kinase Inhibitors as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 884-895

Bentham Science Publishers

Access to resources Recommend Favorite